Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature
Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It is characterized by the proliferation of cancerous cells into the intraluminal space of the blood vessels. It has a low incidence rate of 0.095 cases per 1,000,000. The clinical presentation is insidious and u...
Saved in:
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2020-01-01
|
| Series: | Case Reports in Oncological Medicine |
| Online Access: | http://dx.doi.org/10.1155/2020/7052536 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1832550841539624960 |
|---|---|
| author | Guillermo Enrique Quintero Vega Daniel Osorio José Antonio de la Hoz Valle Daniela Rodríguez Feria |
| author_facet | Guillermo Enrique Quintero Vega Daniel Osorio José Antonio de la Hoz Valle Daniela Rodríguez Feria |
| author_sort | Guillermo Enrique Quintero Vega |
| collection | DOAJ |
| description | Intravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It is characterized by the proliferation of cancerous cells into the intraluminal space of the blood vessels. It has a low incidence rate of 0.095 cases per 1,000,000. The clinical presentation is insidious and unspecific, often delaying the diagnosis. IVLBCL can be diagnosed through body images and histopathology analysis. This neoplasm averages a 60% response rate to current chemotherapy treatment, favoring rituximab, and doxorubicin-based regimen if it is diagnosed in time. Here, we present the case of a 56-year-old man admitted to our hospital with a fever who was eventually diagnosed with IVLBCL. He presented to the consultation with anemia, fever, and splenomegaly. An infection panel, a bone marrow biopsy, and a PET-CT scan were performed and ruled out the possibility of infections and neoplasms. The patient later developed edematous syndrome. As a result, a renal biopsy was performed which tested positive for intravascular large B-cell lymphoma. Currently, the patient has been in complete remission for 33 months. Along with presenting this specific case, we also reviewed previously published cases of IVLBCL to illustrate the renal involvement of this pathology. |
| format | Article |
| id | doaj-art-7533e449226449bf8fc06c93987b3548 |
| institution | Kabale University |
| issn | 2090-6706 2090-6714 |
| language | English |
| publishDate | 2020-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Oncological Medicine |
| spelling | doaj-art-7533e449226449bf8fc06c93987b35482025-02-03T06:05:39ZengWileyCase Reports in Oncological Medicine2090-67062090-67142020-01-01202010.1155/2020/70525367052536Limited Renal Intravascular Lymphoma: A Case Report and Review of the LiteratureGuillermo Enrique Quintero Vega0Daniel Osorio1José Antonio de la Hoz Valle2Daniela Rodríguez Feria3Department of Hematology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, ColombiaDepartment of Hematology, Universidad de los Andes, Bogotá, ColombiaDepartment of Clinical Research, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, ColombiaDepartment of Hematology, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, ColombiaIntravascular large B-cell lymphoma (IVLBCL) is a rare subtype of non-Hodgkin lymphoma. It is characterized by the proliferation of cancerous cells into the intraluminal space of the blood vessels. It has a low incidence rate of 0.095 cases per 1,000,000. The clinical presentation is insidious and unspecific, often delaying the diagnosis. IVLBCL can be diagnosed through body images and histopathology analysis. This neoplasm averages a 60% response rate to current chemotherapy treatment, favoring rituximab, and doxorubicin-based regimen if it is diagnosed in time. Here, we present the case of a 56-year-old man admitted to our hospital with a fever who was eventually diagnosed with IVLBCL. He presented to the consultation with anemia, fever, and splenomegaly. An infection panel, a bone marrow biopsy, and a PET-CT scan were performed and ruled out the possibility of infections and neoplasms. The patient later developed edematous syndrome. As a result, a renal biopsy was performed which tested positive for intravascular large B-cell lymphoma. Currently, the patient has been in complete remission for 33 months. Along with presenting this specific case, we also reviewed previously published cases of IVLBCL to illustrate the renal involvement of this pathology.http://dx.doi.org/10.1155/2020/7052536 |
| spellingShingle | Guillermo Enrique Quintero Vega Daniel Osorio José Antonio de la Hoz Valle Daniela Rodríguez Feria Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature Case Reports in Oncological Medicine |
| title | Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature |
| title_full | Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature |
| title_fullStr | Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature |
| title_full_unstemmed | Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature |
| title_short | Limited Renal Intravascular Lymphoma: A Case Report and Review of the Literature |
| title_sort | limited renal intravascular lymphoma a case report and review of the literature |
| url | http://dx.doi.org/10.1155/2020/7052536 |
| work_keys_str_mv | AT guillermoenriquequinterovega limitedrenalintravascularlymphomaacasereportandreviewoftheliterature AT danielosorio limitedrenalintravascularlymphomaacasereportandreviewoftheliterature AT joseantoniodelahozvalle limitedrenalintravascularlymphomaacasereportandreviewoftheliterature AT danielarodriguezferia limitedrenalintravascularlymphomaacasereportandreviewoftheliterature |